Sandostatin Lar 20 mg powder and solvent for suspension for injection
Land: Bulgarien
Sprache: Bulgarisch
Quelle: ИАЛ - Изпълнителната агенция по лекарствата към Министерството на Здравето на Република България
Gebrauchsinformation
(PIL)
15-01-2024
Fachinformation
(SPC)
30-01-2023
Wirkstoff:
Октреотид
Verfügbar ab:
Novartis Pharma GmbH
ATC-Code:
H01CB2
INN (Internationale Bezeichnung):
Octreotide
Dosierung:
20 mg powder and solvent for suspension for injection
Produktbesonderheiten:
Sandostatin LAR, 20 mg powder and solvent for suspension for injection
Berechtigungsdatum:
2015-03-11
